Reauthorizing the Kay Hagan Tick Act

Floor Speech

Mr. Speaker, I rise in support of H.R. 4348, the Kay Hagan Tick Act, sponsored by my colleagues Chris Smith of New Jersey and Lloyd Doggett of Texas. I understand that Mr. Kean from New Jersey is also a sponsor.

This bill reauthorizes the national strategy and regional centers of excellence in vector-borne diseases. Tick-borne diseases, including Lyme disease, have rapidly increased over the last decades. The Centers for Disease Control and Prevention estimates that nearly a half million people may, in fact, be diagnosed and treated for Lyme disease every year in the United States. That is a dramatic increase from 30,000 annual cases just two decades ago.

H.R. 4348 would expand research, improve testing, and coordinate vector-borne disease efforts across the Federal Government. The bill would also reauthorize funding for Regional Centers of Excellence for surveillance, prevention, and response to vector-borne diseases and reauthorize grants to State health departments to support vector-borne disease infrastructure.

Tick and vector-borne disease have rapidly increased, Mr. Speaker, particularly in the northeastern part of our country. I encourage all of my colleagues to honor the legacy of Senator Kay Hagan, who died of complications from a tick-borne disease, by voting ``yes'' on H.R. 4348.
BREAK IN TRANSCRIPT

Mr. PALLONE. Mr. Speaker, again, I would urge my colleagues to support this bill on a bipartisan basis, and I yield back the balance of my time.

BREAK IN TRANSCRIPT

Source